症状性肝海绵状血管瘤动脉内硬化性栓塞治疗的临床研究

目的 分析症状性肝海绵状血管瘤动脉内硬化性栓塞治疗的临床效果.方法 收集2012年1月至2014年1月收治的60例症状性肝海绵状血管瘤患者临床资料,遵循随机原则,分为观察组与对照组,各30例,对照组采取外科手术治疗,观察组实施平阳霉素碘油乳剂动脉内硬化性栓塞治疗,最后分析两组患者的临床治疗效果.结果 治疗后,观察组患者ALT、AST、TBIL、IBIL、TP等各项肝功能指标改善明显优于对照组,差异有统计学意义（P＜0.05）.观察组住院时间明显短于对照组,差异有统计学意义（P＜0.05）.观察组并发症发生率明显少于对照组,差异有统计学意义（P＜0.05）.结论 动脉内硬化性栓塞治疗症状性肝海绵状血管瘤,有利于保护患者肝功能,降低并发症发生率,缩短住院时间,值得临床推广.

Clinical research on transcatheter arterial embolization on the treatment of symptomatic cavernous hemangioma of the liver

Objective To observe the clinical effects of transcatheter arterial embolization on the treatment of symptomatic cavernous hemangioma of the liver.Methods Totally 60 patients from January 2012 to January 2014 were randomized into two groups：observation group with 30 cases and control group with 30 cases.Control group was treated with surgical operation,and observation group was treated with transcatheter arterial embolization by pingyangmycin lipiodol emulsion.The clinical effect of both groups were analyzed.Results The liver function index such as ALT,AST,TBIL,IBIL,TP in observation group were obviously superior to those of the control group and there was statistical significant difference （P ＜ 0.05）.The hospital stays of observation group was shorter than that of control group （P ＜ 0.05）.The normal tissue complication probability of observation group was less than that in control group （P ＜ 0.05）.Conclusion The use of transcatheter arterial embolization on the treatment of cavernous hemangioma of the liver could protect liver function of patients,reduce the complication possibility and shorten hospital stays.It is worthy of clinical application.